Analysts See $0.50 EPS for Century Communities, Inc. (CCS); Idexx Laboratories Has 0.81 Sentiment

April 22, 2018 - By Vivian Currie

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Logo

Analysts expect Century Communities, Inc. (NYSE:CCS) to report $0.50 EPS on May, 8 after the close.They anticipate $0.10 EPS change or 25.00% from last quarter’s $0.4 EPS. CCS’s profit would be $14.75M giving it 14.65 P/E if the $0.50 EPS is correct. After having $1.01 EPS previously, Century Communities, Inc.’s analysts see -50.50% EPS growth. The stock decreased 2.82% or $0.85 during the last trading session, reaching $29.3. About 211,023 shares traded. Century Communities, Inc. (NYSE:CCS) has risen 20.81% since April 22, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

Idexx Laboratories Inc (IDXX) investors sentiment decreased to 0.81 in Q4 2017. It’s down -0.05, from 0.86 in 2017Q3. The ratio dived, as 201 investment professionals started new or increased equity positions, while 247 decreased and sold their stakes in Idexx Laboratories Inc. The investment professionals in our database reported: 72.13 million shares, down from 87.85 million shares in 2017Q3. Also, the number of investment professionals holding Idexx Laboratories Inc in top ten equity positions decreased from 12 to 11 for a decrease of 1. Sold All: 30 Reduced: 217 Increased: 137 New Position: 64.

Century Communities, Inc. engages in homebuilding business in Atlanta, Central Texas, Colorado, Houston, Nevada, and Utah. The company has market cap of $864.53 million. It is involved in the development, design, construction, marketing, and sale of single-family attached and detached homes, as well as entitlement and development of land. It has a 14.43 P/E ratio. The firm sells homes through its sales representatives, as well as through independent real estate brokers.

Among 6 analysts covering Century Communities (NYSE:CCS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Century Communities had 16 analyst reports since August 12, 2015 according to SRatingsIntel. The company was maintained on Friday, December 29 by Wedbush. The stock of Century Communities, Inc. (NYSE:CCS) earned “Buy” rating by J.P. Morgan on Thursday, September 14. The rating was upgraded by JP Morgan to “Overweight” on Thursday, September 14. JP Morgan maintained it with “Overweight” rating and $37.5 target in Thursday, February 15 report. FBR Capital maintained Century Communities, Inc. (NYSE:CCS) on Thursday, February 23 with “Outperform” rating. The firm has “Buy” rating given on Tuesday, August 8 by Citigroup. On Tuesday, September 20 the stock rating was initiated by Wedbush with “Outperform”. Citigroup initiated Century Communities, Inc. (NYSE:CCS) on Thursday, September 1 with “Buy” rating. Deutsche Bank maintained it with “Buy” rating and $22 target in Monday, May 16 report. Zacks upgraded it to “Hold” rating and $23 target in Wednesday, August 12 report.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on May, 4 before the open. They expect $0.93 earnings per share, up 43.08% or $0.28 from last year’s $0.65 per share. IDXX’s profit will be $80.97M for 52.89 P/E if the $0.93 EPS becomes a reality. After $0.77 actual earnings per share reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts 20.78% EPS growth.

The stock decreased 0.54% or $1.07 during the last trading session, reaching $196.75. About 278,868 shares traded. IDEXX Laboratories, Inc. (IDXX) has risen 23.99% since April 22, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

Capital Counsel Llc Ny holds 9.55% of its portfolio in IDEXX Laboratories, Inc. for 742,729 shares. Fundsmith Llp owns 4.40 million shares or 5.9% of their US portfolio. Moreover, American Capital Management Inc has 4.88% invested in the company for 519,833 shares. The New York-based Tirschwell & Loewy Inc has invested 3.41% in the stock. Bamco Inc Ny, a New York-based fund reported 4.70 million shares.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $17.13 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 66.92 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Since January 1, 0001, it had 2 buys, and 6 sales for $21.47 million activity.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: